CCSG Pilot: Differential Effects of IL-10 on Anti-Tumor Immunity and Mocroenvironmental Factors in CLL

Medicine and Dentistry

1. Chronic Lymphocytic Leukemia 100%
2. Tumor Immunity 100%
3. Cells 38%
4. Growth 27%
5. T Cell 27%
6. B Cell 11%
7. Stromal Cell 11%
8. Patient 11%
9. Aptitude 11%
10. B-Cell Chronic Lymphocytic Leukemia 11%
11. Interleukin 10 5%
12. Diseases 5%
13. Base 5%
14. Gene Expression Profiling 5%
15. T Cell Activation 5%
16. Assay 5%
17. Plasma 5%
18. Cell Proliferation 5%
19. Bone Marrow 5%
20. Immunoregulation 5%
21. Oncogene 5%
22. T-Cell Response 5%
23. Cancer 5%
24. In Vitro 5%
25. Spleen 5%
26. Immunosuppressive Drug 5%
27. Cell Activation 5%
28. Survival 5%
29. Flow Cytometry 5%
30. Cytokine 5%
31. Anti-Inflammatory Drug 5%
32. Dendritic Cell 5%